Skip to main navigation Skip to search Skip to main content

Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.

F. Moosig, E. Reinhold-Keller, E. Csernok, W. L. Gross

Original languageEnglish
JournalArthritis and Rheumatism
Volume41
Issue number3
Pages (from-to)566-567
Number of pages2
ISSN0004-3591
DOIs
Publication statusPublished - 03.1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this